RESUMO
In this review we highlight recent studies that advance the knowledge and understanding of the effects of various environmental factors and associated immune responses in patients with allergic diseases. This review will focus on new literature regarding allergic and immune responses to a variety of environmental factors, including aeroallergens, stinging insects, fungi, pollutants, viral respiratory tract infections, climate change, and microbial exposures.
Assuntos
Infecções Bacterianas/imunologia , Hipersensibilidade/imunologia , Imunidade , Mordeduras e Picadas de Insetos/imunologia , Micoses/imunologia , Doenças Profissionais/imunologia , Viroses/imunologia , Poluentes Atmosféricos/imunologia , Alérgenos/imunologia , Animais , Antígenos de Bactérias/imunologia , Antígenos de Fungos/imunologia , Antígenos Virais/imunologia , Mudança Climática , Exposição Ambiental/efeitos adversos , Humanos , Peçonhas/imunologiaRESUMO
The year 2015 saw a significant number of advances in allergen immunotherapy (AIT), and several of these are reviewed in this report. Although AIT has been used for more than 100 years, investigations into optimal treatment approaches and mechanisms are ongoing. Among the highlights was a report by an international group of experts who reviewed AIT guidelines from the major specialty societies and addressed potential unmet needs. Herein, advances in the effectiveness, safety, and mechanisms of sublingual and oral immunotherapy are reviewed. Development of hypoallergenic vaccines to enhance safety, newer routes and regimens to improve efficacy, and biomarkers to monitor immunotherapy are also discussed.
Assuntos
Dessensibilização Imunológica , Animais , Asma/terapia , Biomarcadores , Hipersensibilidade Alimentar/terapia , Humanos , Rinite Alérgica/terapia , Vacinas/uso terapêuticoAssuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Asma/imunologia , Produtos Biológicos/uso terapêutico , Eosinófilos/imunologia , Inflamação/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Animais , Asma/tratamento farmacológico , Humanos , Inflamação/imunologia , Doença Pulmonar Obstrutiva Crônica/imunologiaRESUMO
In 2014, the Journal published a number of studies that have advanced our understanding of the effects of various environmental factors and immune responses in patients with allergic diseases. In this review we emphasize reports that have appeared in the Journal over the past year that deal with environmental and occupational respiratory disorders and novel approaches to their treatment. The review will focus on the effects of environmental factors and immune responses in allergic airway diseases, identification of new allergens, and risk factors in stinging insect allergy, development of asthma in different age groups, effects of viral infections, and benefits of new therapies.
Assuntos
Alérgenos/imunologia , Hipersensibilidade/imunologia , Doenças Profissionais/imunologia , Doenças Respiratórias/imunologia , Viroses/imunologia , Fatores Etários , Alérgenos/isolamento & purificação , Animais , Exposição Ambiental/efeitos adversos , Humanos , Hipersensibilidade/complicações , Doenças Profissionais/complicações , Exposição Ocupacional/efeitos adversos , Fatores de Risco , Viroses/complicaçõesRESUMO
There is mounting concern for the health of urban populations as cities expand at an unprecedented rate. Urban green spaces provide settings for a remarkable range of physical and mental health benefits, and pioneering health policy is recognizing nature as a cost-effective tool for planning healthy cities. Despite this, limited information on how specific elements of nature deliver health outcomes restricts its use for enhancing population health. We articulate a framework for identifying direct and indirect causal pathways through which nature delivers health benefits, and highlight current evidence. We see a need for a bold new research agenda founded on testing causality that transcends disciplinary boundaries between ecology and health. This will lead to cost-effective and tailored solutions that could enhance population health and reduce health inequalities.
Assuntos
Planejamento de Cidades/normas , Ecossistema , Planejamento Ambiental/normas , Comportamentos Relacionados com a Saúde , Planejamento em Saúde/normas , Saúde da População Urbana , Causalidade , Planejamento de Cidades/economia , Planejamento de Cidades/tendências , Análise Custo-Benefício , Planejamento Ambiental/economia , Planejamento Ambiental/tendências , Planejamento em Saúde/economia , Planejamento em Saúde/tendências , Humanos , NaturezaRESUMO
In this review of articles published in the Journal in 2013, we report on the significant advances in environmental and occupational disorders. Research advances have led to the identification and defined the structure and function of several major allergens. A meta-analysis confirmed the importance of mold exposure in patients with allergic rhinitis, and a new immunologic classification of aspergillosis emerged. Insights into the role of diesel exhaust particles in patients with severe asthma were clarified. Improvements in stinging insect allergy diagnostics were reported. Genetic, immunologic, and biomarker studies advanced the understanding of adverse drug reactions. New practice parameters for cockroach allergen control were presented. The pathologic role of viruses and bacterial agents in patients with asthma and chronic obstructive pulmonary disease were further defined. An excellent review of allergen bronchoprovocation testing was reported. The roles of bronchoprovocation and bronchodilator responsiveness in asthma diagnosis were further clarified. A biomarker for neutrophilic asthma was identified. Therapeutic advances in asthma research include the inhibition of IL-13 by lebrikizumab, use of montelukast in asthmatic smokers, and a thorough review of bronchial thermoplasty in patients with severe asthma. Lastly, maternal asthma was linked to a number of adverse neonatal outcomes.
Assuntos
Aspergilose , Asma , Exposição Ambiental/efeitos adversos , Exposição Ocupacional/efeitos adversos , Doença Pulmonar Obstrutiva Crônica , Anticorpos Monoclonais/uso terapêutico , Aspergilose/diagnóstico , Aspergilose/tratamento farmacológico , Aspergilose/epidemiologia , Aspergilose/etiologia , Aspergilose/metabolismo , Asma/diagnóstico , Asma/tratamento farmacológico , Asma/epidemiologia , Asma/etiologia , Asma/metabolismo , Biomarcadores/metabolismo , Testes de Provocação Brônquica , Feminino , Humanos , Interleucina-13/antagonistas & inibidores , Interleucina-13/metabolismo , Masculino , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Doença Pulmonar Obstrutiva Crônica/etiologia , Doença Pulmonar Obstrutiva Crônica/mortalidadeRESUMO
House dust mites (HDMs) are found in the environments where human habitation exists. Their density is dependent on environmental relative humidity; therefore, higher populations are present in areas of the world with higher humidity levels, e.g., coastal areas and tropics. To date, 24 HDM allergens have been identified. Many of these represent digestive enzymes since HDM feces are the major source of allergen exposure. IgE- medicated sensitization to HDM allergens is an important factor in the pathogenesis of allergic diseases since it is the most common aeroallergen detected by skin testing or in vitro IgE assays. Sensitization to HDM allergens often occurs early in life and appears to play an important role in the progression from allergic rhinitis to asthma (the so-called Allergic March) in children. HDM sensitization is also associated with asthma across all age groups. Efforts to control environmental exposure to HDM allergens have often proven to be unsuccessful. While medications can improve symptoms, only immunotherapy currently provides disease-modifying effects in allergic rhinitis and asthma. Several systemic reviews and meta-analysis indicate that both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are effective in the treatment of allergic rhinitis and asthma for HDM sensitivity. In this report, we review recent studies and the evidence for the use of HDM SCIT and SLIT. Fundamental gaps in knowledge are identified which could lead to improved approaches to HDM allergy.
Assuntos
Antígenos de Dermatophagoides/imunologia , Asma/imunologia , Dermatophagoides pteronyssinus/imunologia , Imunoterapia/métodos , Pyroglyphidae/imunologia , Rinite Alérgica/imunologia , Animais , Asma/terapia , Humanos , Rinite Alérgica/terapiaRESUMO
OBJECTIVE: This paper reports patterns of health service utilisation in the second Australian national survey of psychosis corresponding with changes in available services of this period. METHOD: Semi-structured interviews were carried out of an age-stratified random sample of adults who screened positive for psychosis. Multivariate logistic regressions were used to identify predictors of service use for a sample of 1825 individuals. RESULTS: Use of psychiatric inpatient services was associated with higher symptom levels, suicidal ideation, poor social functioning and younger age. High users of emergency mental health services similarly reported higher symptom levels, poor functioning and younger age, and also reported being married or in a de facto relationship. Recipients of general practitioner services had greater anxiety symptoms and suicidal thoughts, fewer negative symptoms, single marital status and English as their first language. Rehabilitation service use was associated with greater anxiety symptoms, unemployment, younger age of illness onset, living alone and having no dependent children living at home. Last, outpatient/community services were more frequently used by younger people with good premorbid adjustment, hallucinations and a less severe course of illness. CONCLUSIONS: Service utilisation patterns vary with the clinical and socio-demographic features of those who use them - inpatient and emergency service users being similar in such features and differing from users of other services. Comparison with the first national survey of psychosis revealed a significant decline in acute inpatient service use and a substantial increase in the use of outpatient/community and rehabilitation services over the past 10 years.
Assuntos
Serviços Comunitários de Saúde Mental/estatística & dados numéricos , Serviços de Saúde Mental/estatística & dados numéricos , Transtornos Psicóticos/terapia , Centros de Reabilitação/estatística & dados numéricos , Adulto , Austrália , Serviços Comunitários de Saúde Mental/tendências , Feminino , Pesquisas sobre Atenção à Saúde , Hospitalização/estatística & dados numéricos , Hospitalização/tendências , Humanos , Modelos Logísticos , Masculino , Serviços de Saúde Mental/tendências , Pessoa de Meia-Idade , Centros de Reabilitação/tendências , Fatores de RiscoRESUMO
The year 2012 produced a number of advances in our understanding of the effect of environmental factors on allergic diseases, identification of new allergens, immune mechanisms in host defense, factors involved in asthma severity, and therapeutic approaches. This review focuses on the articles published in the Journal in 2012 that enhance our knowledge base of environmental and occupational disorders. Identification of novel allergens can improve diagnostics, risk factor analysis can aid preventative approaches, and studies of genetic-environmental interactions and immune mechanisms will lead to better therapeutics.
Assuntos
Exposição Ambiental/efeitos adversos , Hipersensibilidade/etiologia , Doenças Profissionais/etiologia , Poluição do Ar/efeitos adversos , Alérgenos/efeitos adversos , Animais , Asma/etiologia , Asma/terapia , Humanos , Hipersensibilidade/terapia , Imunoterapia , Fatores de RiscoRESUMO
Asthma is a common disorder that in 2009 afflicted 8.2% of adults and children, 24.6 million persons, in the United States. In patients with moderate and severe persistent asthma, there is significantly increased morbidity, use of health care support, and health care costs. Epidemiologic studies in the United States and Europe have associated mold sensitivity, particularly to Alternaria alternata and Cladosporium herbarum, with the development, persistence, and severity of asthma. In addition, sensitivity to Aspergillus fumigatus has been associated with severe persistent asthma in adults. Allergic bronchopulmonary aspergillosis (ABPA) is caused by A fumigatus and is characterized by exacerbations of asthma, recurrent transient chest radiographic infiltrates, coughing up thick mucus plugs, peripheral and pulmonary eosinophilia, and increased total serum IgE and fungus-specific IgE levels, especially during exacerbation. The airways appear to be chronically or intermittently colonized by A fumigatus in patients with ABPA. ABPA is the most common form of allergic bronchopulmonary mycosis (ABPM); other fungi, including Candida, Penicillium, and Curvularia species, are implicated. The characteristics of ABPM include severe asthma, eosinophilia, markedly increased total IgE and specific IgE levels, bronchiectasis, and mold colonization of the airways. The term severe asthma associated with fungal sensitization (SAFS) has been coined to illustrate the high rate of fungal sensitivity in patients with persistent severe asthma and improvement with antifungal treatment. The immunopathology of ABPA, ABPM, and SAFS is incompletely understood. Genetic risks identified in patients with ABPA include HLA association and certain T(H)2-prominent and cystic fibrosis variants, but these have not been studied in patients with ABPM and SAFS. Oral corticosteroid and antifungal therapies appear to be partially successful in patients with ABPA. However, the role of antifungal and immunomodulating therapies in patients with ABPA, ABPM, and SAFS requires additional larger studies.
Assuntos
Pneumopatias Fúngicas , Hipersensibilidade Respiratória , Antígenos de Fungos/imunologia , Mudança Climática , Humanos , Imunoterapia , Pneumopatias Fúngicas/genética , Pneumopatias Fúngicas/metabolismo , Pneumopatias Fúngicas/terapia , Hipersensibilidade Respiratória/genética , Hipersensibilidade Respiratória/metabolismo , Hipersensibilidade Respiratória/terapiaRESUMO
Training for health services staff often focuses on improving individual practitioner's knowledge and skills, with less emphasis given to the broader organizational context, in particular those elements that support successful implementation of changes post-training. This paper compares the effectiveness of a standard training model for suicide prevention to an enhanced training model. The training involved the public mental health workforce throughout the State of Queensland, Australia and was developed in collaboration with the State health department and as such took place within a policy and practice context. The standard training involved participation in a one-day training workshop, which provided information on evidence-based suicide prevention strategies. The enhanced model took an organizational development approach and incorporated a focus on creating and strengthening networks to enhance the capacity of mental health service staff to undertake preventive strategies. Findings suggest that multi-component organizational approaches for suicide prevention produces benefits that should now be trialled through experimental approaches.
Assuntos
Fortalecimento Institucional/organização & administração , Serviços Comunitários de Saúde Mental/organização & administração , Eficiência Organizacional , Pessoal de Saúde/educação , Prevenção do Suicídio , Adulto , Austrália , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Programas e Projetos de Saúde/métodos , Inquéritos e Questionários , Adulto JovemRESUMO
BACKGROUND: Health literacy is the ability to obtain, interpret and use health information. Low rates of health literacy in Australia have been suggested, but no validated measure exists. OBJECTIVE: To explore health literacy competencies in a sample of community pharmacy consumers. DESIGN: Structured interviews were undertaken by a team of researchers during August, 2009. The instrument was derived from available literature, measuring aspects of functional, interactive and critical health literacy regarding use of medicines. SETTING AND PARTICIPANTS: Twelve community pharmacies in the Brisbane region, Australia. RESULTS: Six hundred and forty-seven consumers participated; 64% were women. A wide distribution of ages was evident. English was the first language of 89% of respondents. More than half of the sample (55%), predominantly aged 26-45 years, was tertiary educated. While 87% of respondents recognized a sample prescription, 20% could not readily match the prescription to a labelled medicine box. Eighty-two percentage of respondents interpreted 'three times a day' appropriately, but interpretation of a standard ancillary label was highly variable. Advanced age, less formal education, non-English-speaking background and male gender were independently related to lower performance in some variables. DISCUSSION: This health literacy measure applied comprehension and numeracy skills required of adults receiving prescription medications. While the majority of consumers adequately performed these tasks, some behaviours and responses were of sufficient concern to propose additional verbal and written information interventions by pharmacy staff. CONCLUSIONS: This research provides insight into issues that may affect consumers' appropriate use of medicines and self-efficacy. Initiatives to improve public health literacy are warranted.
Assuntos
Letramento em Saúde , Pacientes/psicologia , Farmácias , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Letramento em Saúde/estatística & dados numéricos , Humanos , Entrevistas como Assunto , Masculino , Pessoa de Meia-Idade , Queensland , Adulto JovemRESUMO
OBJECTIVE: Participation in mainstream education and employment facilitates both the recovery and the social inclusion of people with psychotic disorders. As part of the second Australian survey of psychosis, we assessed labour force activity and participation in formal education among working age adults with psychotic disorders. METHOD: Data were drawn from a large national community prevalence survey of adults with psychotic disorders. Known as the Survey of High Impact Psychosis (SHIP), it was conducted in seven Australian catchment areas during March to December 2010. Current and past year labour force activity, current employment, past year participation in formal education and vocational training, and key clinical and demographic characteristics were examined in a sample of 1825 participants. RESULTS: Only 22.4% of people with psychotic disorders were found to be employed (either full-time or part-time) in the month prior to the survey. In the previous 12 months, 32.7% were employed at some time. Of those in competitive employment, the majority worked part-time (63.9%), while a quarter worked 38 or more hours per week (23.4%). In terms of educational attainment, 18.4% reported difficulties with reading or writing, while 31.9% completed high school, which represents 12 years of formal education. CONCLUSIONS: The proportion currently employed has remained stable at 22% since the last national survey in 1997. Policy makers and service providers could do more to ensure people with psychotic disorders obtain access to more effective forms of assistance with respect to both their continuing education and employment. More effective vocational and educational interventions for people with psychotic disorders appear to be urgently needed.
Assuntos
Escolaridade , Emprego , Pessoas Mentalmente Doentes , Transtornos Psicóticos , Atividades Cotidianas , Adulto , Austrália/epidemiologia , Área Programática de Saúde , Serviços Comunitários de Saúde Mental/normas , Serviços Comunitários de Saúde Mental/estatística & dados numéricos , Feminino , Necessidades e Demandas de Serviços de Saúde , Inquéritos Epidemiológicos , Humanos , Masculino , Estado Civil , Pessoas Mentalmente Doentes/psicologia , Pessoas Mentalmente Doentes/estatística & dados numéricos , Pessoa de Meia-Idade , Participação do Paciente/estatística & dados numéricos , Escalas de Graduação Psiquiátrica , Transtornos Psicóticos/classificação , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/epidemiologia , Transtornos Psicóticos/psicologia , Educação VocacionalRESUMO
OBJECTIVE: The 2010 Survey of High Impact Psychosis (SHIP) is Australia's second national psychosis survey. This paper provides an overview of its findings, including comparisons with the first psychosis survey and general population data. METHODS: The survey covered 1.5 million people aged 18-64 years, approximately 10% of Australians in this age group. A two-phase design was used. In phase 1, screening for psychosis took place in public mental health services and non-government organizations supporting people with mental illness. In phase 2, 1825 of those screen-positive for psychosis were randomly selected and interviewed. Data collected included symptomatology, substance use, functioning, service utilization, medication use, education, employment, housing, and physical health including fasting blood samples. RESULTS: The estimated 1-month treated prevalence of psychotic disorders in public treatment services was 3.1 people per 1000 population; the 12-month treated prevalence was 4.5 people per 1000. The majority (63.0%) of participants met ICD-10 criteria for schizophrenia/schizoaffective disorder. One-half (49.5%) reported attempting suicide in their lifetime and two-thirds (63.2%) were rated as impaired in their ability to socialize. Over half (54.8%) had metabolic syndrome. The proportion currently smoking was 66.1%. Educational achievement was low. Only 21.5% were currently employed. Key changes in the 12 years since the first survey included: a marked drop in psychiatric inpatient admissions; a large increase in the proportion attending community mental health clinics; increased use of rehabilitation services and non-government organizations supporting people with mental illness; a major shift from typical to atypical antipsychotics; and large increases in the proportions with lifetime alcohol or drug abuse/dependence. CONCLUSION: People with psychotic illness face multiple challenges. An integrated approach to service provision is needed to ensure that their living requirements and needs for social participation are met, in addition to their very considerable mental and physical health needs.
Assuntos
Antipsicóticos/uso terapêutico , Transtornos Psicóticos , Transtornos Relacionados ao Uso de Substâncias , Tentativa de Suicídio , Atividades Cotidianas , Adulto , Austrália/epidemiologia , Área Programática de Saúde/estatística & dados numéricos , Comorbidade , Feminino , Disparidades nos Níveis de Saúde , Inquéritos Epidemiológicos , Hospitalização/estatística & dados numéricos , Humanos , Classificação Internacional de Doenças , Masculino , Serviços de Saúde Mental/estatística & dados numéricos , Pessoa de Meia-Idade , Prevalência , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/tratamento farmacológico , Transtornos Psicóticos/epidemiologia , Transtornos Psicóticos/psicologia , Distribuição Aleatória , Fatores Socioeconômicos , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/psicologia , Tentativa de Suicídio/psicologia , Tentativa de Suicídio/estatística & dados numéricosRESUMO
2010 Found a number of significant advances in environmental and occupational respiratory disease. The role of sensitization and the subsequent production of allergic disease have been explored. New allergens and their T- and B-cell epitopes have been characterized. Novel approaches to the diagnosis and evaluation of food allergy have been described. The role of pollutants as they affect respiratory disease and the effects of age extremes on sensitization and asthma have been addressed. Significant advances in the understanding of inflammatory changes in both the upper and lower respiratory systems occurred. Novel therapeutic approaches have been explored, including the development of hypoallergens from improved molecular biology techniques. New effective approaches to asthma therapy have been identified. Exposure reduction through air filtration and novel immunotherapy approaches, such as sublingual therapy, have made significant advances.
Assuntos
Exposição Ambiental , Doenças Profissionais/imunologia , Exposição Ocupacional , Doenças Respiratórias/imunologia , Agonistas Adrenérgicos beta/uso terapêutico , Alérgenos/química , Asma/tratamento farmacológico , Química Farmacêutica/tendências , Humanos , Hipersensibilidade , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Respiratórias/diagnóstico , Doenças Respiratórias/tratamento farmacológicoRESUMO
BACKGROUND: Few trials of sublingual immunotherapy (SLIT) in the United States have been reported. OBJECTIVE: This randomized, placebo-controlled feasibility SLIT study compared the safety and physiologic effects of high- versus low-dose Dermatophagoides farinae vaccine. METHODS: Thirty-one D farinae-sensitive adults with allergic rhinitis with or without mild intermittent asthma were eligible for randomization to high-dose maintenance vaccine (n = 10, 4200 allergen units [approximately 70 µg of Der f 1/d]), low-dose maintenance vaccine (n = 10; 60 allergen units [approximately 1 µg of Der f 1/d]), or placebo (n = 11) over 12 to 18 months. Medication-symptom scores and adverse events were monitored, serum D farinae-specific IgE and IgG4 levels were measured, and bronchial reactivity to D farinae was determined at baseline and 6-month intervals. RESULTS: Of the 31 randomized subjects, 6 withdrew because of non-treatment-ascribed events. Four withdrew because of treatment-ascribed effects: high-dose group, 1 of 10 (gastrointestinal symptoms); low-dose group, 1 of 10 (gastrointestinal symptoms); and placebo group, 2 of 11 (headache and increased nasal symptoms). Thus 21 subjects completed the study: high-dose group, 9; low-dose group, 7; and placebo group, 5. Eleven of the 21 subjects experienced mild-to-moderate gastrointestinal symptoms, throat irritation, or both (high-dose group, 5/9; low-dose group, 4/7; and placebo group, 2/5). No severe systemic reactions were noted. No differences in symptom-medication scores were found. High-dose SLIT increased the bronchial threshold to allergen challenge and increased serum D farinae-specific IgG4 levels, whereas low-dose SLIT and placebo had no significant effect. CONCLUSIONS: High-dose D farinae SLIT was generally tolerable, increased serum D farinae-specific IgG4 levels, and improved the bronchial threshold to allergen challenge. Larger US trials are warranted.
Assuntos
Antígenos de Dermatophagoides/administração & dosagem , Dessensibilização Imunológica/efeitos adversos , Dessensibilização Imunológica/métodos , Pyroglyphidae/imunologia , Rinite Alérgica Perene/prevenção & controle , Administração Sublingual , Animais , Antígenos de Dermatophagoides/efeitos adversos , Proteínas de Artrópodes , Cisteína Endopeptidases , Método Duplo-Cego , Estudos de Viabilidade , Feminino , Humanos , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Masculino , Resultado do Tratamento , Estados UnidosRESUMO
The year 2009 led to a number of significant advances in environmental and occupational allergic diseases. The role of exposure to environmental pollutants, respiratory viruses, and allergen exposure showed significant advances. New allergens were identified. Occupational asthma and the relationship of complementary and alternative medicine to allergic diseases were extensively reviewed. New approaches to immunotherapy, novel vaccine techniques, and methods to reduce risks for severe allergic disease were addressed.
Assuntos
Exposição Ambiental/efeitos adversos , Hipersensibilidade/imunologia , Pneumopatias/imunologia , Doenças Profissionais/imunologia , Exposição Ocupacional/efeitos adversos , Animais , Terapias Complementares/tendências , Humanos , Hipersensibilidade/tratamento farmacológico , Hipersensibilidade/etiologia , Imunoterapia/métodos , Pneumopatias/tratamento farmacológico , Pneumopatias/etiologia , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/etiologia , Fatores de RiscoRESUMO
BACKGROUND: Specific allergen immunotherapy is most often delivered subcutaneously, but sublingual immunotherapy may confer greater benefit in terms of tolerability and safety, accessibility, and improved antigen delivery. OBJECTIVE: This randomized, double-blind, placebo-controlled trial was conducted to identify a safe and effective maintenance dose range of sublingual standardized glycerinated short ragweed pollen extract in adults with ragweed-induced rhinoconjunctivitis. METHODS: In May 2006, a total of 115 patients with ragweed-induced rhinoconjunctivitis were randomly allocated to placebo (n = 40), medium-dose extract (4.8 microg Amb a 1/d; n = 39), or high-dose extract (48 microg Amb a 1/d; n = 36). In a 1-day (rush) dose-escalation regimen, ragweed pollen extract was administered sublingually in incremental doses until maximum tolerable or scheduled dose was reached and then maintained during the ragweed pollen season. Patient diaries were used to monitor nasal and ocular symptoms and medication. The primary endpoint was symptom score. RESULTS: Both active treatment groups achieved a 15% reduction in total rhinoconjunctivitis symptom scores compared with placebo during the entire ragweed pollen season, but the difference was not statistically significant (P > .10) However, in an analysis of covariance correcting for preseasonal symptoms, both mean daily symptom scores (0.19 +/- 1.16 vs 1.00 +/- 2.30) and medication scores (0.0003 +/- 1.64 vs 0.63 +/- 1.06) for the entire pollen season were significantly reduced in the high-dose versus placebo groups, respectively (P Assuntos
Alérgenos/administração & dosagem
, Conjuntivite Alérgica/prevenção & controle
, Dessensibilização Imunológica/métodos
, Rinite Alérgica Sazonal/prevenção & controle
, Administração Sublingual
, Adulto
, Alérgenos/efeitos adversos
, Ambrosia/imunologia
, Dessensibilização Imunológica/efeitos adversos
, Método Duplo-Cego
, Feminino
, Humanos
, Masculino
, Pessoa de Meia-Idade
, Pólen/imunologia
, Adulto Jovem
RESUMO
Substantial progress in understanding the role of environmental factors in allergic disease and asthma has been made in the past year. A number of new allergens have been described, and the impact of exposure to indoor allergens in the development of allergic respiratory disease is further confirmed. Exposures to environmental pollutants, particularly tobacco smoke in children, have furthered our knowledge of the detrimental effects of these exposures. This review highlights key advances in environmental and occupational exposures that contribute to the burden of allergic respiratory disease.
Assuntos
Alérgenos/imunologia , Doença Ambiental/imunologia , Hipersensibilidade/imunologia , Doenças Profissionais/imunologia , Hipersensibilidade Respiratória/imunologia , Poluição do Ar em Ambientes Fechados , Animais , Biomarcadores , Reações Cruzadas/imunologia , Exposição Ambiental , Doença Ambiental/diagnóstico , Doença Ambiental/etiologia , Doença Ambiental/terapia , Fungos/imunologia , Humanos , Hipersensibilidade/diagnóstico , Hipersensibilidade/etiologia , Hipersensibilidade/terapia , Doenças Profissionais/diagnóstico , Doenças Profissionais/etiologia , Doenças Profissionais/terapia , Exposição Ocupacional , Hipersensibilidade Respiratória/diagnóstico , Hipersensibilidade Respiratória/etiologia , Hipersensibilidade Respiratória/terapia , Poluição por Fumaça de TabacoRESUMO
Sensitivity to the fungus Alternaria is associated with asthma persistence and severity. Current therapeutic options for treating Alternaria-induced airway inflammation are limited. In this study, Brown Norway rats are used to study the effectiveness of a DNA-based vaccine delivered to the airway in attenuating the response to a major Alternaria allergen, rAlt a 2. Compared to untreated sensitized animals, or animals receiving an "out-of-frame" DNA-based vaccine, animals treated with "in-frame" DNA vaccine showed an attenuation in specific IgE antibody titers to rAlt a 2, an increase in IgG(2b) (a Th1 response), a reduction in spontaneous IL-13 release by peribronchial lymph node cell suspensions, and an attenuation in the decrease in total lung capacity 72 h post-allergen challenge. Further, histopathologic examination of the lung tissues revealed reduced pulmonary inflammation post-allergen challenge in the DNA-vaccine-treated compared to sensitized, untreated animals. We conclude that a DNA-based vaccine delivered to the airway significantly influences the immunologic, pulmonary physiologic, and histological alterations induced by challenge with a major Alternaria allergen, rAlt a 2, in sensitized animals.